OPKO Health
OPK
#5858
Rank
A$1.60 B
Marketcap
A$2.02
Share price
-0.74%
Change (1 day)
-18.80%
Change (1 year)

Earnings for OPKO Health (OPK)

Earnings in 2025 (TTM): -A$0.25 Billion

According to OPKO Health 's latest financial reports the company's current earnings are A$0.64 Billion. In 2024 the company made an earning of -A$15.61 Million, an increase over its 2023 earnings that were of -A$0.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for OPKO Health from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.25 Billion1474.83%
2024 -A$15.61 Million-94.38%
2023 -A$0.28 Billion-52.92%
2022 -A$0.59 Billion2691.58%
2021 -A$21.12 Million-128.81%
2020 A$73.29 M-115.96%
2019 -A$0.46 Billion72.03%
2018 -A$0.27 Billion-33.83%
2017 -A$0.41 Billion264.29%
2016 -A$0.12 Billion-46.71%
2015 -A$0.21 Billion-19.31%
2014 -A$0.26 Billion64.11%
2013 -A$0.16 Billion180.06%
2012 -A$56.03 Million53.56%
2011 -A$36.49 Million55.87%
2010 -A$23.41 Million-48.27%
2009 -A$45.25 Million-24.64%
2008 -A$60.04 Million-85.11%
2007 -A$0.41 Billion6.61%
2006 -A$0.38 Billion18539.02%
2005 -A$2.03 Million-32.33%
2004 -A$3 Million-45.53%
2003 -A$5.51 Million-64.7%
2002 -A$15.6 Million2.99%
2001 -A$15.15 Million16.9%
2000 -A$12.96 Million104.81%
1999 -A$6.33 Million40.03%
1998 -A$4.52 Million-0%
1997 -A$4.52 Million7.14%
1996 -A$4.22 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$48.77 B-20,413.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$12.25 B-5,202.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$7.74 B-3,326.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$2.66 B-1,211.12%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Alnylam Pharmaceuticals
ALNY
A$0.19 B-181.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.09 B-5,137.03%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$2.00 B-935.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-A$83.64 Million-65.17%๐Ÿ‡บ๐Ÿ‡ธ USA